Literature DB >> 15505380

Assessing the severity of the small inframe deletion mutation in the alpha-subunit of beta-hexosaminidase A found in the Turkish population by reproducing it in the more stable beta-subunit.

I Sinici1, M B Tropak, D J Mahuran, H A Ozkara.   

Abstract

GM(2) gangliosidoses are a group of panethnic lysosomal storage diseases in which GM(2) ganglioside accumulates in the lysosome due to a defect in one of three genes, two of which encode the alpha- or beta-subunits of beta- N -acetylhexosaminidase (Hex) A. A small inframe deletion mutation in the catalytic domain of the alpha-subunit of Hex has been found in five Turkish patients with infantile Tay-Sachs disease. To date it has not been detected in other populations and is the only mutation to be found in exon 10. It results in detectable levels of inactive alpha-protein in its precursor form. Because the alpha- and beta-subunits share 60% sequence identity, the Hex A and Hex B genes are believed to have arisen from a common ancestral gene. Thus the subunits must share very similar three-dimensional structures with conserved functional domains. Hex B, the beta-subunit homodimer is more stable than the heterodimeric Hex A, and much more stable than Hex S, the alpha homodimer. Thus, mutations that completely destabilize the alpha-subunit can often be partially rescued if expressed in the aligned positions in the beta-subunit. To better understand the severity of the Turkish HEXA mutation, we reproduced the 12 bp deletion mutation (1267-1278) in the beta-subunit cDNA. Western blot analysis of permanently transfected CHO cells expressing the mutant detected only the pro-form of the beta-subunit coupled with a total lack of detectable Hex B activity. These data indicate that the deletion of the four amino acids severely affects the folding of even the more stable beta-subunit, causing its retention in the endoplasmic reticulum and ultimate degradation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15505380      PMCID: PMC2910077          DOI: 10.1023/B:BOLI.0000045759.12935.76

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  31 in total

Review 1.  Quality control in the endoplasmic reticulum.

Authors:  Lars Ellgaard; Ari Helenius
Journal:  Nat Rev Mol Cell Biol       Date:  2003-03       Impact factor: 94.444

2.  Characterization of two Turkish beta-hexosaminidase mutations causing Tay-Sachs disease.

Authors:  Hatice Asuman Ozkara; Konrad Sandhoff
Journal:  Brain Dev       Date:  2003-04       Impact factor: 1.961

Review 3.  Chemical chaperones: a pharmacological strategy for disorders of protein folding and trafficking.

Authors:  David H Perlmutter
Journal:  Pediatr Res       Date:  2002-12       Impact factor: 3.756

Review 4.  Biochemical consequences of mutations causing the GM2 gangliosidoses.

Authors:  D J Mahuran
Journal:  Biochim Biophys Acta       Date:  1999-10-08

5.  The X-ray crystal structure of human beta-hexosaminidase B provides new insights into Sandhoff disease.

Authors:  Timm Maier; Norbert Strater; Christina G Schuette; Ralf Klingenstein; Konrad Sandhoff; Wolfram Saenger
Journal:  J Mol Biol       Date:  2003-05-02       Impact factor: 5.469

6.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

7.  Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3'-splice site selection and cause Sandhoff disease.

Authors:  M Fujimaru; A Tanaka; K Choeh; N Wakamatsu; H Sakuraba; G Isshiki
Journal:  Hum Genet       Date:  1998-10       Impact factor: 4.132

8.  A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside.

Authors:  Rohita Sharma; Scott Bukovac; John Callahan; Don Mahuran
Journal:  Biochim Biophys Acta       Date:  2003-01-20

9.  Biochemical and molecular characterization of mutant hexosaminidase A in a Turkish family.

Authors:  Incilay Sinici; H Asuman Ozkara; Meral Topçu; Gönenç Ciliv
Journal:  Pediatr Int       Date:  2003-02       Impact factor: 1.524

Review 10.  Small-molecule therapeutics for the treatment of glycolipid lysosomal storage disorders.

Authors:  Terry D Butters; Howard R Mellor; Keishi Narita; Raymond A Dwek; Frances M Platt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

View more
  2 in total

1.  Comparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines.

Authors:  Incilay Sinici; Maryam Zarghooni; Michael B Tropak; Don J Mahuran; H Asuman Ozkara
Journal:  Biochem Genet       Date:  2006-04-28       Impact factor: 1.890

2.  Three novel mutations in Iranian patients with Tay-Sachs disease.

Authors:  Solmaz Jamali; Nasim Eskandari; Omid Aryani; Shadab Salehpour; Talieh Zaman; Behnam Kamalidehghan; Massoud Houshmand
Journal:  Iran Biomed J       Date:  2014
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.